397 related articles for article (PubMed ID: 22474127)
21. Effect of a novel non-thiazolidinedione peroxisome proliferator-activated receptor alpha/gamma agonist on glucose uptake.
Hu X; Feng Y; Liu X; Zhao XF; Yu JH; Yang YS; Sydow-Bäckman M; Hörling J; Zierath JR; Leng Y
Diabetologia; 2007 May; 50(5):1048-57. PubMed ID: 17333104
[TBL] [Abstract][Full Text] [Related]
22. Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions.
Schopfer FJ; Cole MP; Groeger AL; Chen CS; Khoo NK; Woodcock SR; Golin-Bisello F; Motanya UN; Li Y; Zhang J; Garcia-Barrio MT; Rudolph TK; Rudolph V; Bonacci G; Baker PR; Xu HE; Batthyany CI; Chen YE; Hallis TM; Freeman BA
J Biol Chem; 2010 Apr; 285(16):12321-33. PubMed ID: 20097754
[TBL] [Abstract][Full Text] [Related]
23. Oral administration of a PPAR-delta agonist to rodents worsens, not improves, maximal insulin-stimulated glucose transport in skeletal muscle of different fibers.
Cresser J; Bonen A; Chabowski A; Stefanyk LE; Gulli R; Ritchie I; Dyck DJ
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R470-9. PubMed ID: 20538899
[TBL] [Abstract][Full Text] [Related]
24. Skeletal muscle reprogramming by activation of calcineurin improves insulin action on metabolic pathways.
Ryder JW; Bassel-Duby R; Olson EN; Zierath JR
J Biol Chem; 2003 Nov; 278(45):44298-304. PubMed ID: 12941959
[TBL] [Abstract][Full Text] [Related]
25. Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PGC-1alpha) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats.
Benton CR; Holloway GP; Han XX; Yoshida Y; Snook LA; Lally J; Glatz JF; Luiken JJ; Chabowski A; Bonen A
Diabetologia; 2010 Sep; 53(9):2008-19. PubMed ID: 20490453
[TBL] [Abstract][Full Text] [Related]
26. Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake.
Storz P; Döppler H; Wernig A; Pfizenmaier K; Müller G
Eur J Biochem; 1999 Nov; 266(1):17-25. PubMed ID: 10542046
[TBL] [Abstract][Full Text] [Related]
27. Peroxisome proliferator-activated receptor-γ in capillary endothelia promotes fatty acid uptake by heart during long-term fasting.
Goto K; Iso T; Hanaoka H; Yamaguchi A; Suga T; Hattori A; Irie Y; Shinagawa Y; Matsui H; Syamsunarno MR; Matsui M; Haque A; Arai M; Kunimoto F; Yokoyama T; Endo K; Gonzalez FJ; Kurabayashi M
J Am Heart Assoc; 2013 Jan; 2(1):e004861. PubMed ID: 23525438
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor-γ activation enhances insulin-stimulated glucose disposal by reducing ped/pea-15 gene expression in skeletal muscle cells: evidence for involvement of activator protein-1.
Ungaro P; Mirra P; Oriente F; Nigro C; Ciccarelli M; Vastolo V; Longo M; Perruolo G; Spinelli R; Formisano P; Miele C; Beguinot F
J Biol Chem; 2012 Dec; 287(51):42951-61. PubMed ID: 23105093
[TBL] [Abstract][Full Text] [Related]
29. Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists.
Cha BS; Ciaraldi TP; Park KS; Carter L; Mudaliar SR; Henry RR
Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E151-9. PubMed ID: 15727952
[TBL] [Abstract][Full Text] [Related]
30. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate.
Schmitz-Peiffer C; Craig DL; Biden TJ
J Biol Chem; 1999 Aug; 274(34):24202-10. PubMed ID: 10446195
[TBL] [Abstract][Full Text] [Related]
31. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes.
Chavez JA; Summers SA
Arch Biochem Biophys; 2003 Nov; 419(2):101-9. PubMed ID: 14592453
[TBL] [Abstract][Full Text] [Related]
32. Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells.
Abbot EL; McCormack JG; Reynet C; Hassall DG; Buchan KW; Yeaman SJ
FEBS J; 2005 Jun; 272(12):3004-14. PubMed ID: 15955060
[TBL] [Abstract][Full Text] [Related]
33. Effects of PPARs agonists on cardiac metabolism in littermate and cardiomyocyte-specific PPAR-γ-knockout (CM-PGKO) mice.
Barbieri M; Di Filippo C; Esposito A; Marfella R; Rizzo MR; D'Amico M; Ferraraccio F; Di Ronza C; Duan SZ; Mortensen RM; Rossi F; Paolisso G
PLoS One; 2012; 7(4):e35999. PubMed ID: 22563432
[TBL] [Abstract][Full Text] [Related]
34. Rosiglitazone increases fatty acid Δ9-desaturation and decreases elongase activity index in human skeletal muscle in vivo.
Mai K; Andres J; Bobbert T; Assmann A; Biedasek K; Diederich S; Graham I; Larson TR; Pfeiffer AF; Spranger J
Metabolism; 2012 Jan; 61(1):108-16. PubMed ID: 21741058
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of contraction and PPAR agonists on the expression of fatty acid transporters in rat skeletal muscle.
Benton CR; Koonen DP; Calles-Escandon J; Tandon NN; Glatz JF; Luiken JJ; Heikkila JJ; Bonen A
J Physiol; 2006 May; 573(Pt 1):199-210. PubMed ID: 16484294
[TBL] [Abstract][Full Text] [Related]
36. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
Díaz-Delfín J; Morales M; Caelles C
Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
[TBL] [Abstract][Full Text] [Related]
37. Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta.
Krämer DK; Al-Khalili L; Perrini S; Skogsberg J; Wretenberg P; Kannisto K; Wallberg-Henriksson H; Ehrenborg E; Zierath JR; Krook A
Diabetes; 2005 Apr; 54(4):1157-63. PubMed ID: 15793256
[TBL] [Abstract][Full Text] [Related]
38. Palmitate-induced down-regulation of sortilin and impaired GLUT4 trafficking in C2C12 myotubes.
Tsuchiya Y; Hatakeyama H; Emoto N; Wagatsuma F; Matsushita S; Kanzaki M
J Biol Chem; 2010 Nov; 285(45):34371-81. PubMed ID: 20805226
[TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle.
Cha BS; Ciaraldi TP; Carter L; Nikoulina SE; Mudaliar S; Mukherjee R; Paterniti JR; Henry RR
Diabetologia; 2001 Apr; 44(4):444-52. PubMed ID: 11357475
[TBL] [Abstract][Full Text] [Related]
40. Increased glucose utilization and decreased fatty acid metabolism in myotubes from Glmp(gt/gt) mice.
Kong XY; Feng YZ; Eftestøl E; Kase ET; Haugum H; Eskild W; Rustan AC; Thoresen GH
Arch Physiol Biochem; 2016; 122(1):36-45. PubMed ID: 26707125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]